Literature DB >> 14395272

Serum properdin levels in hemorrhagic shock.

E FRANK, J FINE, L PILLEMER.   

Abstract

Entities:  

Keywords:  HEMORRHAGE/experimental; SERUM GLOBULIN; SHOCK/experimental

Mesh:

Substances:

Year:  1955        PMID: 14395272     DOI: 10.3181/00379727-89-21764

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  14 in total

1.  [Effect of hypothermia and antibiotics on survival of dogs after controlled hypotension].

Authors:  V D MAGAZINOVIC; S CENIC-SUSNIK; D VARENIKA
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1959

2.  The problem of irreversible shock.

Authors:  F G SMIDDY
Journal:  Postgrad Med J       Date:  1959-10       Impact factor: 2.401

3.  [The properdin problem].

Authors:  H E SCHULTZE; G SCHWICK
Journal:  Blut       Date:  1958-11

4.  [Mechanisms of nonspecific infection resistance].

Authors:  D BOHME
Journal:  Klin Wochenschr       Date:  1958-09-15

5.  Germfree animals in surgical research.

Authors:  S M LEVENSON; R P MASON; T E HUBER; O J MALM; R E HOROWITZ; A EINHEBER
Journal:  Ann Surg       Date:  1959-10       Impact factor: 12.969

6.  Experimental studies of the in vivo relationships of the properdin system to resistance to infection.

Authors:  O A ROSS
Journal:  Am J Pathol       Date:  1958 May-Jun       Impact factor: 4.307

7.  [Complement factors and properdin in a healthy infant during the first year of life].

Authors:  F KOCH; H E SCHULTZE; G SCHWICK
Journal:  Klin Wochenschr       Date:  1958-01-01

8.  [Body defense against bacterial infection in traumatic shock].

Authors:  J FINE
Journal:  Klin Wochenschr       Date:  1957-10-01

9.  [Role of the properdin system in the normal and stimulated blood cell structure].

Authors:  H FISCHER; W FRITZSCHE; H ARGENTON
Journal:  Klin Wochenschr       Date:  1958-05-01

10.  The properdin system and immunity. V. The bactericidal activity of the properdin system.

Authors:  A C WARDLAW; L PILLEMER
Journal:  J Exp Med       Date:  1956-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.